Alercell Launches Website Dedicated to New Cancer Detection Tests
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read MorePosted by Andy Lundin | Jan 25, 2023 | Company News, Leukemia |
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read MorePosted by Andy Lundin | Jan 17, 2023 | Molecular Diagnostics |
Optical genome mapping can outperform standard tests used for common blood cancers and help make better, more specific, diagnosis.
Read MorePosted by Andy Lundin | Dec 30, 2022 | Leukemia |
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
Read MorePosted by Andy Lundin | Dec 13, 2022 | Cancer |
A new clinical tool pinpoints which clonal hematopoiesis patients are at highest risk for cancer progression.
Read MorePosted by Chris Wolski | Nov 28, 2022 | Flow Cytometry, Lab Automation |
The ongoing clinical laboratory labor shortage is putting a strain on the U.S. healthcare system, but automation can help clinical labs cope.
Read More